Capehorn MS - Search Results

1

Reductions in Insulin Resistance are Mediated Primarily via Weight Loss in Subjects With Type 2 Diabetes on Semaglutide.

Fonseca VA, Capehorn MS, Garg SK, Jódar Gimeno E, Hansen OH, Holst AG, Nayak G, Seufert J. Fonseca VA, et al. Among authors: capehorn ms. J Clin Endocrinol Metab. 2019 Sep 1;104(9):4078-4086. doi: 10.1210/jc.2018-02685. J Clin Endocrinol Metab. 2019. PMID: 30938762

2

Efficacy and Safety of Once-Weekly Semaglutide Versus Exenatide ER in Subjects With Type 2 Diabetes (SUSTAIN 3): A 56-Week, Open-Label, Randomized Clinical Trial.

Ahmann AJ, Capehorn M, Charpentier G, Dotta F, Henkel E, Lingvay I, Holst AG, Annett MP, Aroda VR. Ahmann AJ, et al. Diabetes Care. 2018 Feb;41(2):258-266. doi: 10.2337/dc17-0417. Epub 2017 Dec 15. Diabetes Care. 2018. PMID: 29246950 Clinical Trial.

3

Efficacy and safety of once-weekly semaglutide 1.0mg vs once-daily liraglutide 1.2mg as add-on to 1-3 oral antidiabetic drugs in subjects with type 2 diabetes (SUSTAIN 10).

Capehorn MS, Catarig AM, Furberg JK, Janez A, Price HC, Tadayon S, Vergès B, Marre M. Capehorn MS, et al. Diabetes Metab. 2020 Apr;46(2):100-109. doi: 10.1016/j.diabet.2019.101117. Epub 2019 Sep 17. Diabetes Metab. 2020. PMID: 31539622 Clinical Trial.

4

Impact of baseline characteristics and beta-cell function on the efficacy and safety of subcutaneous once-weekly semaglutide: A patient-level, pooled analysis of the SUSTAIN 1-5 trials.

Aroda VR, Capehorn MS, Chaykin L, Frias JP, Lausvig NL, Macura S, Lüdemann J, Madsbad S, Rosenstock J, Tabak O, Tadayon S, Bain SC. Aroda VR, et al. Among authors: capehorn ms. Diabetes Obes Metab. 2020 Mar;22(3):303-314. doi: 10.1111/dom.13896. Epub 2019 Nov 14. Diabetes Obes Metab. 2020. PMID: 31608552 Free PMC article.

5

Once-Weekly Semaglutide Reduces HbA_1c and Body Weight in Patients with Type 2 Diabetes Regardless of Background Common OAD: a Subgroup Analysis from SUSTAIN 2-4 and 10.

Capehorn M, Ghani Y, Hindsberger C, Johansen P, Jódar E. Capehorn M, et al. Diabetes Ther. 2020 May;11(5):1061-1075. doi: 10.1007/s13300-020-00796-z. Epub 2020 Mar 19. Diabetes Ther. 2020. PMID: 32193837 Free PMC article.

6

Efficacy of Once-Weekly Semaglutide vs Empagliflozin Added to Metformin in Type 2 Diabetes: Patient-Level Meta-analysis.

Lingvay I, Capehorn MS, Catarig AM, Johansen P, Lawson J, Sandberg A, Shaw R, Paine A. Lingvay I, et al. Among authors: capehorn ms. J Clin Endocrinol Metab. 2020 Dec 1;105(12):e4593-604. doi: 10.1210/clinem/dgaa577. J Clin Endocrinol Metab. 2020. PMID: 32827435 Free PMC article.

7

Proportion of participants with type 2 diabetes achieving a metabolic composite endpoint with once-weekly semaglutide treatment versus comparators: Post hoc pooled analysis from SUSTAIN 1-5, 7-10 and SUSTAIN China.

Ji L, Ahmann AJ, Ahrén B, Capehorn MS, Hu P, Lingvay I, Liu W, Rodbard HW, Shen Z, Sorli C. Ji L, et al. Among authors: capehorn ms. Diabetes Obes Metab. 2024 Jan;26(1):233-241. doi: 10.1111/dom.15309. Epub 2023 Oct 12. Diabetes Obes Metab. 2024. PMID: 37822270 Clinical Trial.

8

Oral Semaglutide Versus Empagliflozin, Sitagliptin and Liraglutide in the UK: Long-Term Cost-Effectiveness Analyses Based on the PIONEER Clinical Trial Programme.

Bain SC, Hansen BB, Malkin SJP, Nuhoho S, Valentine WJ, Chubb B, Hunt B, Capehorn M. Bain SC, et al. Diabetes Ther. 2020 Jan;11(1):259-277. doi: 10.1007/s13300-019-00736-6. Epub 2019 Dec 12. Diabetes Ther. 2020. PMID: 31833042 Free PMC article.

9

A Relative Cost of Control Analysis of Once-Weekly Semaglutide Versus Exenatide Extended-Release, Dulaglutide and Liraglutide in the UK.

Johansen P, Sandberg A, Capehorn M. Johansen P, et al. Adv Ther. 2020 Mar;37(3):1248-1259. doi: 10.1007/s12325-020-01242-z. Epub 2020 Feb 11. Adv Ther. 2020. PMID: 32048148 Free PMC article.

10

Evaluating the Long-Term Cost-Effectiveness of Once-Weekly Semaglutide Versus Once-Daily Liraglutide for the Treatment of Type 2 Diabetes in the UK.

Johansen P, Chubb B, Hunt B, Malkin SJP, Sandberg A, Capehorn M. Johansen P, et al. Adv Ther. 2020 May;37(5):2427-2441. doi: 10.1007/s12325-020-01337-7. Epub 2020 Apr 18. Adv Ther. 2020. PMID: 32306244 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

28 results

Search Page